CXCR2通过ABT-263影响放疗抵抗性HPV阴性头颈部鳞癌细胞
本研究探讨ABT-263联合光子照射对HPV阴性头颈部鳞状细胞癌细胞(Cal33和UPCI:SCC040)的放疗增敏作用及其与CXCR2信号的关系。结果显示ABT-263通过抑制Bcl-xL和激活Bax诱导凋亡并减少衰老,但CXCR2表达变化影响放疗增敏效果,伴随CXCR2抑制可克服UPCI:SCC040细胞的放疗抵抗。
要点
- ABT-263通过抑制Bcl-xL和激活Bax诱导HPV阴性HNSCC细胞凋亡并降低衰老水平。
- Cal33细胞中CXCR2显著下调且ABT-263放疗增敏,而UPCI:SCC040细胞中CXCR2诱导且克隆存活未受影响。
- 同时抑制CXCR2可恢复UPCI:SCC040细胞的放疗增敏,且增敏效应不源于DNA损伤增加。
核心结论
- CXCR2介导的信号在HPV阴性HNSCC细胞放疗抵抗中起核心作用,ABT-263联合CXCR2抑制可增强放疗敏感性。
研究设计与样本
- 使用HPV阴性HNSCC细胞系Cal33和UPCI:SCC040,联合ABT-263与光子照射,进行功能与机制实验评估活力、凋亡、衰老、分泌蛋白、克隆存活和DNA修复。
主要发现
- ABT-263通过抑制Bcl-xL和激活Bax诱导凋亡,并降低照射后衰老水平。
- Cal33细胞中CXCR2强烈下调,ABT-263降低活力和克隆存活,实现放疗增敏。
- UPCI:SCC040细胞中CXCR2表达被诱导,活力降低但克隆存活未受影响;同时抑制CXCR2可实现放疗增敏。
- 放疗增敏效应不归因于DNA损伤增加,依据γH2AX/53BP1共定位。
关键数值与推荐
- 在Cal33细胞中,ABT-263联合照射降低活力和克隆存活,伴随CXCR2强烈下调。
- 在UPCI:SCC040细胞中,ABT-263联合照射诱导CXCR2表达,活力降低但克隆存活不受影响;同时抑制CXCR2可增敏。
临床怎么用
- 对于HPV阴性HNSCC,ABT-263联合放疗可能有效,但需考虑CXCR2表达状态,高表达者可能需联合CXCR2抑制。
局限性
- 研究仅使用两种细胞系,未涉及体内实验或临床样本,结论需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Radiation-induced senescence strongly contributes to therapy resistance in HPV-negative head and neck squamous cell carcinoma (HNSCC). In particular, the NF-[Formula: see text]B-dependent arm of the senescence-associated secretory phenotype (SASP) activates signaling pathways that are tightly associated with, and promote, resistance to irradiation. In addition to the SASP, another hallmark of senescence is the upregulation of anti-apoptotic proteins. The BH3-only mimetic ABT-263 has been shown to effectively eliminate senescent cells. In this study, we employed ABT-263 to overcome the therapy-induced resistance in HNSCC cells and uncovered a link to chemokine signaling. METHODS: The HNSCC cell lines Cal33 and UPCI:SCC040 were treated with a combination of ABT-263 and photon irradiation, followed by functional and mechanistic assays assessing viability, apoptosis, senescence, secreted proteins, clonogenic survival, and DNA repair. RESULTS: Functionally, ABT-263 induced apoptosis via impeding Bcl-xL and activating Bax. Senescence levels were reduced after irradiation. Mechanistically, we observed cell-line- and protein-specific changes in the SASP, including a striking difference in CXCR2 receptor expression. Cal33 cells exhibited strong downregulation of CXCR2 and were radiosensitized by ABT-263, as indicated by reduced viability and clonogenic survival. In contrast, CXCR2 expression was induced in UPCI:SCC040 cells following treatment; although viability was diminished, clonogenic survival remained unaffected. Notably, radiosensitization in UPCI:SCC040 cells could be achieved through concomitant inhibition of CXCR2. Furthermore, the radiosensitizing effect was not attributable to increased DNA damage, as evidenced by γH2AX/53BP1 co-localization. CONCLUSIONS: These findings highlight a central role for CXCR2-mediated signaling in the development of radioresistance in HPV-negative HNSCC cells. CLINICAL TRIAL NUMBER: Not applicable.
引用
- Kohl S, Schaper M, Lajarín JA, et al. CXCR2 affects sensitization of radioresistant HPV-negative head and neck squamous cell carcinoma cells by ABT-263. Radiat Oncol. 2026. PMID: 41680869. doi:10.1186/s13014-026-02798-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。